Logos Global Management LP Centessa Pharmaceuticals PLC Transaction History

Logos Global Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.18 - $9.85 $174,085 - $539,228	-54,744 Reduced 12.04%	399,801 $1.95 Million
Q4 2021 Feb 14, 2022	SELL	$10.99 - $17.54 $6.76 Million - $10.8 Million	-615,000 Reduced 57.5%	454,545 $5.12 Million
Q3 2021 Nov 15, 2021	BUY	$16.7 - $23.11 $2.17 Million - $3 Million	130,000 Added 13.84%	1,069,545 $17.9 Million
Q2 2021 Aug 16, 2021	BUY	$21.71 - $25.66 $20.4 Million - $24.1 Million	939,545 New	939,545 $20.9 Million

108

118M

5.9K

53K

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.61B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.